disodium [4-[pyridin-2-yl-(4-sulfonatooxyphenyl)methyl]phenyl] sulfate | South Africa Drug Approvals | Medicines Control Council | PharmaCompass.com

Please Wait

Applying Filters...

disodium;[4-[pyridin-2-yl-(4-sulfonatooxyphenyl)methyl]phenyl] sulfate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

23 API Suppliers, 3 USDMF, 3 CEP/COS, 4 JDMF, 4 EU WC, 4 NDC API, 19 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

FINISHED DOSAGE FORMULATIONS

24 FDF Dossiers, 4 FDA Orange Book, 12 Europe, 3 Canada, 1 South Africa, 4 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FOR SOLUTION;ORAL - 12GM/PACKET;3.5GM/PACKET;10MG/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;ORAL - 12GM/BOT;3.5GM/BOT;10MG/BOT

RELATED EXCIPIENT COMPANIES

3 Rochem International Inc, 1 DKSH, 1 Pharm-RX Chemical, 1 Faran Shimi Pharmaceutical, 2 Gangwal Healthcare, 1 Actylis, 1 Bioplus Life Sciences, 1 Pluviaendo

DIGITAL CONTENT

7 NEWS #PharmaBuzz

7 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

4 Finished Drug Prices, 1 Annual Reports

MARKET PLACE

15 APIs

15 APIs

PATENTS & EXCLUSIVITIES

5 US Patents

5 US Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 2 USP, 2 Others

$ Xls

Filters

Filters

FILTER :

filter Applicant Reset all filters

1 All

01 1Ferring (Pty) Ltd

filter Active Ingredients Reset all filters

filter Dosage Form Reset all filters

filter Brand Name Reset all filters

List of Suppliers

Product Main Page

01

Ferring (Pty) Ltd

American Pharma Summit

Not Confirmed

Contact us
to update this info